Related Experiment Video
Updated: Sep 6, 2025

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
Published on: March 7, 2025
Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a
Jennifer H Ku1, Myron J Levin2, Yi Luo1
1Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Insights
Individuals with Down syndrome (DS) have a lower risk of COVID-19 infection but a significantly higher risk of severe disease. Enhanced monitoring and early treatment are crucial for this population.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- Down syndrome (DS) is linked to immune deficiencies, increasing infection susceptibility.
- The specific risk of severe coronavirus disease 2019 (COVID-19) in individuals with DS has not been clearly established.
Purpose of the Study:
- To evaluate the risk of COVID-19 infection and severe disease in individuals with Down syndrome.
- To compare these risks against matched controls in a pre-vaccination era.
Main Methods:
- A matched cohort study design was employed.
- 2,541 individuals with DS were matched with 10,164 controls based on age, sex, and race/ethnicity.
- Multivariable Cox proportional hazard regression analysis was used to assess risk.
Main Results:
- Individuals with DS showed a 32% lower rate of COVID-19 infection compared to controls (aHR, 0.68).
- Conversely, individuals with DS had a 6-fold higher rate of severe COVID-19 disease (aHR, 6.14).
Conclusions:
- Despite a lower infection rate, individuals with Down syndrome face a substantially higher risk of severe COVID-19 outcomes.
- Recommendations include enhanced infection surveillance, prompt treatment, and COVID-19 vaccination promotion for the DS population.
Background:
Down syndrome (DS) is associated with an increased risk of infections attributed to immune defects. Whether individuals with DS are at an increased risk of severe coronavirus disease 2019 (COVID-19) remains unclear.
Methods:
In a matched cohort study, we evaluated the risk of COVID-19 infection and severe COVID-19 disease in individuals with DS and their matched counterparts in a pre-COVID-19 vaccination period at Kaiser Permanente Southern California. Multivariable Cox proportion hazard regression was used to investigate associations between DS and risk of COVID-19 infection and severe COVID-19 disease.
Results:
Our cohort included 2541 individuals with DS and 10 164 without DS matched on age, sex, and race/ethnicity (51.6% female, 53.3% Hispanic, median age 25 years [interquartile range, 14-38]). Although the rate of COVID-19 infection in individuals with DS was 32% lower than their matched counterparts (adjusted hazard ratio [aHR], 0.68; 95% confidence interval [CI], .56-.83), the rate of severe COVID-19 disease was 6-fold higher (aHR, 6.14; 95% CI, 1.87-20.16).
Conclusions:
Although the risk of COVID-19 infection is lower, the risk of severe disease is higher in individuals with DS compared with their matched counterparts. Better infection monitoring, early treatment, and promotion of vaccine for COVID-19 are warranted for DS populations.
Related Concept Videos
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Meiosis I
Single Nucleotide Polymorphisms-SNPs
Relative Risk
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

